Seasons Greetings from the Team at The Sentiment!
We’ll now be taking some time off to enjoy with our families but below are a few of the most popular stories of 2022 and look forward to returning in the New Year.
ASX News
International Bank of Australia approved to launch Australia’s newest payments bank
RATs – The ASX-listed companies manufacturing Rapid Antigen Tests that you cannot buy
A step closer towards scarless wound healing: Pharmaxis drug through Phase 1 trial
Has this tech company just pulled off the Sale of the Century?
1 million US students undergoing Family Zone trials to negate online porn risks
A tale of investment advice, Equity Story seeks $4.5m for IPO chapter
High profile investors target Metaverse assets with ASX reject now valued at $5 billion
Woolworths wage rort bill now upwards of $500 million
Cirrus whips backhander at WebCentral upon concession of failed hostile takeover
Oventus bites the dust as sleep apnea mouthguards fall into slumber with administrators called in
Opinion
In the wake of MYOB, is Reckon now one of the most undervalued stocks on the ASX?
Pass go, collect mortgage: Why the Government’s latest first home buyer’s scheme is crap
What is the impact of geopolitical events on markets?
Existential childcare crisis: G8 Education appoints discount retail boss as CEO
Stay positive when inflation strikes
Satire
Australia to close borders to Omicron Persei 8
Old timer utterly confused by MCG hipster menu responsible for 40 minute queues
Call of Duty gamer reckons he can end the Ukraine war
Office worker feigns disappointment about return to working from home
Sydney office worker claims ‘week of mourning’ not related to AFL Grand Final
To all of our loyal readers and social media followers, we thank you for your ongoing readership and are delighted to make your investing experience better.
Regards,
Conor Murphy
Editor
Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…
Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…
Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…
Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…
The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…
Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…